| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 132.834 | 153.635 | 156.659 | 174.332 | - | 215.298 | 245.217 | 279.384 | 269.214 |
| Total Income - EUR | 0 | 132.837 | 153.676 | 156.694 | 174.589 | - | 215.358 | 245.272 | 279.415 | 269.269 |
| Total Expenses - EUR | 11.028 | 114.629 | 135.706 | 141.739 | 154.310 | - | 190.769 | 217.910 | 234.185 | 247.984 |
| Gross Profit/Loss - EUR | -11.028 | 18.209 | 17.970 | 14.954 | 20.280 | - | 24.588 | 27.362 | 45.230 | 21.285 |
| Net Profit/Loss - EUR | -11.028 | 16.880 | 14.966 | 12.992 | 18.536 | - | 22.435 | 25.041 | 42.558 | 13.208 |
| Employees | 1 | 2 | 2 | 2 | 2 | - | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Orion Pharma Romania Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 |
| Current Assets | 23.598 | 146.402 | 37.633 | 58.621 | 77.070 | - | 123.020 | 151.204 | 201.621 | 157.624 |
| Inventories | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 |
| Receivables | 1.030 | 134.767 | 21.612 | 22.522 | 29.905 | - | 37.585 | 51.139 | 102.899 | 101.921 |
| Cash | 22.568 | 11.635 | 16.021 | 36.098 | 47.165 | - | 85.436 | 100.066 | 98.723 | 55.703 |
| Shareholders Funds | -10.983 | 6.009 | 20.873 | 33.482 | 51.369 | - | 88.717 | 114.033 | 156.245 | 118.322 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | - | 40 | 41 | 40 | 40 |
| Debts | 35.183 | 142.019 | 18.405 | 25.220 | 27.613 | - | 35.786 | 38.829 | 47.177 | 41.512 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7312 - 7312" | |||||||||
| CAEN Financial Year |
7312
|
|||||||||
Comments - Orion Pharma Romania Srl